These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26097064)

  • 1. PEGylation to Improve Protein Stability During Melt Processing.
    Lee P; Towslee J; Maia J; Pokorski J
    Macromol Biosci; 2015 Oct; 15(10):1332-7. PubMed ID: 26097064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylation enhances protein stability during encapsulation in PLGA microspheres.
    Diwan M; Park TG
    J Control Release; 2001 Jun; 73(2-3):233-44. PubMed ID: 11516501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Milling solid proteins to enhance activity after melt-encapsulation.
    Lee PW; Maia J; Pokorski JK
    Int J Pharm; 2017 Nov; 533(1):254-265. PubMed ID: 28939464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres.
    Castellanos IJ; Al-Azzam W; Griebenow K
    J Pharm Sci; 2005 Feb; 94(2):327-40. PubMed ID: 15570602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.
    Yoncheva K; Lambov N; Miloshev S
    Drug Dev Ind Pharm; 2009 Apr; 35(4):449-54. PubMed ID: 19288298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation-induced aggregation and loss in activity of gamma-chymotrypsin and their prevention.
    Castellanos IJ; Cruz G; Crespo R; Griebenow K
    J Control Release; 2002 Jun; 81(3):307-19. PubMed ID: 12044569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein loaded biodegradable microspheres based on PLGA-protein bioconjugates.
    Nam YS; Park TG
    J Microencapsul; 1999; 16(5):625-37. PubMed ID: 10499842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
    Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of lysozyme structure and function upon encapsulation and release from poly(lactic-co-glycolic) acid microspheres prepared by the water-in-oil-in-water method.
    Pérez C; De Jesús P; Griebenow K
    Int J Pharm; 2002 Nov; 248(1-2):193-206. PubMed ID: 12429473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
    Jiang G; Woo BH; Kang F; Singh J; DeLuca PP
    J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved lysozyme stability and release properties of poly(lactide-co-glycolide) implants prepared by hot-melt extrusion.
    Ghalanbor Z; Körber M; Bodmeier R
    Pharm Res; 2010 Feb; 27(2):371-9. PubMed ID: 20033474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of Lysozyme-PLGA-Loaded Microparticles for Controlled Release Using Hot-Melt Extrusion.
    Farinha S; Moura C; Afonso MD; Henriques J
    AAPS PharmSciTech; 2020 Oct; 21(7):274. PubMed ID: 33033873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the optimization of drug delivery to the cochlear apex: Influence of polymer and drug selection in biodegradable intracochlear implants.
    Lehner E; Honeder C; Knolle W; Binder W; Scheffler J; Plontke SK; Liebau A; Mäder K
    Int J Pharm; 2023 Aug; 643():123268. PubMed ID: 37488058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microencapsulation of PEGylated adenovirus within PLGA microspheres for enhanced stability and gene transfection efficiency.
    Mok H; Park JW; Park TG
    Pharm Res; 2007 Dec; 24(12):2263-9. PubMed ID: 17929147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.
    Cu Y; Saltzman WM
    Mol Pharm; 2009; 6(1):173-81. PubMed ID: 19053536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface Mechanical and Rheological Behaviors of Biocompatible Poly((D,L-lactic acid-ran-glycolic acid)-block-ethylene glycol) (PLGA-PEG) and Poly((D,L-lactic acid-ran-glycolic acid-ran-ε-caprolactone)-block-ethylene glycol) (PLGACL-PEG) Block Copolymers at the Air-Water Interface.
    Kim HC; Lee H; Khetan J; Won YY
    Langmuir; 2015 Dec; 31(51):13821-33. PubMed ID: 26633595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biomimetic approach to active self-microencapsulation of proteins in PLGA.
    Shah RB; Schwendeman SP
    J Control Release; 2014 Dec; 196():60-70. PubMed ID: 25219750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrophilic poly (ethylene glycol) capped poly (lactic-co-glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats.
    S S; S M; P S L S; S S; S B; V P
    Int J Biol Macromol; 2017 Feb; 95():1190-1198. PubMed ID: 27825822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release.
    Rietscher R; Czaplewska JA; Majdanski TC; Gottschaldt M; Schubert US; Schneider M; Lehr CM
    Int J Pharm; 2016 Mar; 500(1-2):187-95. PubMed ID: 26784983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.